Form DEF 14A BioXcel Therapeutics, For: May 19

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. META
10. TLT

Go back to Form DEF 14A BioXcel Therapeutics, For: May 19

BioXcel Therapeutics (BTAI) PT Raised to $76 at Jefferies

April 6, 2022 11:40 AM EDT

Jefferies analyst Chris Howerton raised the price target on BioXcel Therapeutics (NASDAQ: BTAI) to $76.00 (from $73.00) while maintaining a Buy rating on FDA Approval of IGALMI Sublingual Film.

The analyst noted the label was broad, pricing is soon, and trade-launch in Q3.

... More